How a Google DeepMind Spin-off Hunts Hidden Drug Targets
Evolving story · 1 updatesIsomorphic Labs' AI Drug Discovery ProgressTimeline →Isomorphic Labs, a Google DeepMind spin-off, advances AI-driven drug discovery by leveraging protein structure prediction to sign major drug-discovery partnerships.
For more than a decade, artificial intelligence has been touted as a way to dramatically accelerate drug discovery. Yet despite billions of dollars in investment, relatively few AI-designed medicines have made it to patients. That’s partially because the timelines for careful drug testing can’t be easily compressed—and partially because drug development is just really hard.
Isomorphic Labs, the Google DeepMind spin-off that’s building on DeepMind’s Nobel Prize-winning work on protein structure prediction, may be making the most progress. The company has signed major drug-discovery partnership
Source: How a Google DeepMind Spin-off Hunts Hidden Drug Targets. Read the full piece at the source.
Summary and analysis generated by AI (mistral). Always verify against the original sources.
Employers who laid off workers citing AI are already starting to regret it - CNBC
Ford rehires ‘gray beard’ engineers after AI falls short
HP Inc. launches Frontier strategic partnership with OpenAI
